DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus

Area of Science:

• Microbiology
• Immunology
• Vaccine Development

Background:

• Adhesins are critical virulence factors in early Staphylococcus aureus infections.
• Antibodies targeting adhesins can reduce bacterial adherence and promote phagocytosis.

Purpose of the Study:

• To evaluate the immune response in mice to a DNA vaccine encoding clumping factor A (ClfA).
• To assess the efficacy of ClfA-directed antibodies in reducing Staphylococcus aureus virulence.

Main Methods:

• Mice were immunized with plasmids expressing the fibrinogen-binding region of ClfA.
• Immune response was assessed via antibody production and splenocyte proliferation assays.
• In vitro assays evaluated bacterial binding, phagocytosis, and in vivo virulence in a mastitis model.

Main Results:

• DNA vaccination induced a strong, specific antibody response to ClfA.
• Splenocyte proliferation confirmed cellular immune involvement.
• Pre-incubation with vaccinated mouse serum reduced Staphylococcus aureus fibrinogen binding by 92%.
• Vaccine-induced antibodies enhanced bacterial phagocytosis in vitro and reduced virulence in a mouse mastitis model.
• No protection was observed against intraperitoneal challenge.

Conclusions:

• DNA immunization against ClfA is a promising strategy for combating Staphylococcus aureus infections by targeting adhesins.
• This approach elicits specific antibodies and enhances host immune mechanisms against the pathogen.
• Further research may be warranted to optimize vaccine efficacy against systemic infections.